Novavax
NVAX
#5751
Rank
S$1.45 B
Marketcap
S$8.95
Share price
0.73%
Change (1 day)
-19.40%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of September 2025 : -S$0.21 Billion

According to Novavax's latest financial reports the company has -S$0.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-S$0.85 Billion-10.44%
2023-12-31$-S$0.95 Billion11.39%
2022-12-31$-S$0.86 Billion78.79%
2021-12-31$-S$0.48 Billion-157.3%
2020-12-31$S$0.82 B-430.87%
2019-12-31$-S$0.26 Billion9.31%
2018-12-31$-S$0.23 Billion68.61%
2017-12-31$-S$0.14 Billion1595.17%
2016-12-31$-S$8.03 Million-101.94%
2015-12-31$S$0.41 B36.45%
2014-12-31$S$0.30 B17.83%
2013-12-31$S$0.25 B162.41%
2012-12-31$S$98.12 M40.71%
2011-12-31$S$69.73 M-8.32%
2010-12-31$S$76.06 M-22.55%
2009-12-31$S$98.2 M50.96%
2008-12-31$S$65.05 M-28.32%
2007-12-31$S$90.75 M-37.04%
2006-12-31$S$0.14 B74.36%
2005-12-31$S$82.67 M52.26%
2004-12-31$S$54.29 M-11.09%
2003-12-31$S$61.06 M335.96%
2002-12-31$S$14 M-72.48%
2001-12-31$S$50.89 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-S$0.37 Billion 79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.71 B-942.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.75 B-471.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.51 Billion 147.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$59.57 B-29,442.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$120.64 B-59,520.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$57.99 B-28,664.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
S$9.74 M-104.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$27.44 B-13,616.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
S$0.77 B-481.92%๐Ÿ‡บ๐Ÿ‡ธ USA